Table 3.

Antiviral treatment

	Received treatment (N = 18)	Untreated (N = 11)
Media age (IQR)—years	47.5 (45–55.7)	39 (35–53)
Female sex—n (%)	13 (72.2%)	5 (45.4%)
Covid-19 pneumonia—n (%)	11 (61.1%)	4 (36.3%)
Covid-19 severity—n (%)
Mild	5 (27.7%)	2 (18.1%)
Moderate	4 (22.2%)	2 (18.1%)
Severe	9 (50%)	7 (63.6%)
COVID-19 acute antiviral treatment—n (%)	13 (72.2%)	6 (54.5%)
Positive results of plasma PCR—n (%)	9 (50%)	4 (36%)
At least one positive PCR—n (%)	10 (55.5%)	5 (45.4%)
Basal functional status
Grade 0—n (%)	0 (0%)	0 (0%)
Grade I—n (%)	1 (5.5%)	6 (54.54%)
Grade II—n (%)	5 (27.7%)	3 (27.27%)
Grade III—n (%)	4 (22.2%)	1 (9%)
Grade IV—n (%)	8 (44.4%)	1 (9%)

n  number